Subscribe
istock-512332386_bakhtiar_zein
bakhtiarzein / iStockphoto.com
26 June 2017Americas

FDA targets barriers to generic competition

The Food and Drug Administration (FDA) has announced its intention to target the barriers to generic drug competition.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
FDA issues new guidance to boost generic competition
3 October 2017   The US Food and Drug Administration has issued new guidance as part of its bid to target the barriers to generic drug competition.
Americas
FDA identifies companies ‘potentially blocking access’ to drug samples
21 May 2018   The US Food and Drug Administration has published a list of companies that it suspects might be preventing generic drug producers accessing samples of branded products.
Americas
USFDA to modernise generic review with $37.6m funding
19 June 2018   The US Food and Drug Administration is planning to use new budget funding to modernise generic drug review and promote more widespread use of generics.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Americas
FDA issues new guidance to boost generic competition
3 October 2017   The US Food and Drug Administration has issued new guidance as part of its bid to target the barriers to generic drug competition.
Americas
FDA identifies companies ‘potentially blocking access’ to drug samples
21 May 2018   The US Food and Drug Administration has published a list of companies that it suspects might be preventing generic drug producers accessing samples of branded products.
Americas
USFDA to modernise generic review with $37.6m funding
19 June 2018   The US Food and Drug Administration is planning to use new budget funding to modernise generic drug review and promote more widespread use of generics.

More on this story

Americas
FDA issues new guidance to boost generic competition
3 October 2017   The US Food and Drug Administration has issued new guidance as part of its bid to target the barriers to generic drug competition.
Americas
FDA identifies companies ‘potentially blocking access’ to drug samples
21 May 2018   The US Food and Drug Administration has published a list of companies that it suspects might be preventing generic drug producers accessing samples of branded products.
Americas
USFDA to modernise generic review with $37.6m funding
19 June 2018   The US Food and Drug Administration is planning to use new budget funding to modernise generic drug review and promote more widespread use of generics.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool
USPTO clarifies AI's role in patent eligibility